Brandywine Global Investment Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-392,118
Closed -$8.09M 595
2024
Q3
$8.09M Sell
392,118
-43,513
-10% -$898K 0.05% 308
2024
Q2
$6.75M Buy
435,631
+64,248
+17% +$995K 0.05% 339
2024
Q1
$5.92M Buy
371,383
+192,853
+108% +$3.07M 0.04% 379
2023
Q4
$3M Sell
178,530
-38,679
-18% -$650K 0.02% 489
2023
Q3
$2.54M Buy
217,209
+4,700
+2% +$54.9K 0.02% 508
2023
Q2
$2.86M Sell
212,509
-1,000
-0.5% -$13.4K 0.02% 490
2023
Q1
$3.54M Hold
213,509
0.03% 465
2022
Q4
$3.97M Hold
213,509
0.03% 438
2022
Q3
$2.74M Sell
213,509
-8,758
-4% -$112K 0.03% 476
2022
Q2
$1.56M Sell
222,267
-32,400
-13% -$227K 0.01% 568
2022
Q1
$2.11M Hold
254,667
0.02% 535
2021
Q4
$1.72M Sell
254,667
-96,975
-28% -$656K 0.01% 544
2021
Q3
$1.86M Buy
351,642
+2,014
+0.6% +$10.7K 0.01% 534
2021
Q2
$2.01M Sell
349,628
-4,259
-1% -$24.5K 0.01% 536
2021
Q1
$1.63M Sell
353,887
-3,438
-1% -$15.8K 0.01% 541
2020
Q4
$1.19M Sell
357,325
-92,355
-21% -$308K 0.01% 522
2020
Q3
$1.34M Buy
449,680
+108,890
+32% +$324K 0.01% 491
2020
Q2
$1.58M Buy
340,790
+3,228
+1% +$14.9K 0.02% 477
2020
Q1
$1.3M Buy
337,562
+2,150
+0.6% +$8.28K 0.02% 493
2019
Q4
$1.27M Buy
335,412
+53,735
+19% +$203K 0.01% 557
2019
Q3
$1.5M Sell
281,677
-67,395
-19% -$358K 0.01% 555
2019
Q2
$1.34M Buy
349,072
+135,597
+64% +$521K 0.01% 568
2019
Q1
$1.09M Buy
+213,475
New +$1.09M 0.01% 539